Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · IEX Real-Time Price · USD
0.630
0.00 (-0.02%)
Jul 22, 2024, 9:54 AM EDT - Market open
Kezar Life Sciences Employees
Kezar Life Sciences had 58 employees as of December 31, 2023. The number of employees decreased by 26 or -30.95% compared to the previous year.
Employees
58
Change (1Y)
-26
Growth (1Y)
-30.95%
Revenue / Employee
$120,690
Profits / Employee
-$1,747,052
Market Cap
46.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Apyx Medical | 252 |
Vicarious Surgical | 131 |
Carisma Therapeutics | 107 |
NextCure | 82 |
Lucid Diagnostics | 70 |
Elicio Therapeutics | 32 |
Matinas BioPharma Holdings | 32 |
Protara Therapeutics | 27 |
KZR News
- 11 days ago - Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 4 months ago - Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update - Business Wire
- 5 months ago - Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference - Business Wire
- 5 months ago - Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis - Business Wire
- 8 months ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) - PRNewsWire